Group Founder
Stanley Chang
- MD in Medicine (National Taiwan University College of Medicine)
- Ph.D. in Biophysics (UCL, University of London, UK)
Stanley has more than 40 years of experience in the biomedical industry. He began his career at National Taiwan University Hospital as a resident and a chief resident in the department of urology. He also served as the chairman of department of urology at Tzu-Chi General Hospital. He established Medigen Biotechnology Corp. (MBC) focusing on the development of new therapies for liver diseases and cancers. in late 1999. MBC has now gradually developed into a comprehensive biopharmaceutical corporation with business fields covering new drug development, innovative drug discovery, molecular diagnostics, vaccine, and generic drugs.